title: Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer.
authors.affiliation: Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
authors.forename: David
authors.initials: D
authors.lastname: Neal
authors.affiliation: Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Departments of Laboratory Medicine, Surgery (Urology), and Medicine (Genitourinary Oncology), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden. Electronic address: liljah@mskcc.org.
authors.forename: Hans
authors.initials: H
authors.lastname: Lilja
mesh_terms: D014408:Biomarkers, Tumor; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D011471:Prostatic Neoplasms
chemical_list: D014408:Biomarkers, Tumor